Kristina I. Nesterova

Kristina I. Nesterova

Auto-generated profile, based on publicly available information

Kristina I. Nesterova

University of Toronto

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Alcohol
Verified
Journal Article
Closed access
VPValentina N. Perfilova
Valentina N. Perfilova
MKMargarita V. Kustova
Margarita V. Kustova
TPTamara A. Popova
Tamara A. Popova
GKGulnara H. Khusainova
Gulnara H. Khusainova
IPIgor I. Prokofiev
Igor I. Prokofiev
ITIvan N. Tyurenkov
Ivan N. Tyurenkov

4 March 2023 in Annals of the Russian academy of medical sciences
Verified
Journal Article
Open access
PDF file
KNKristina I. Nesterova
Kristina I. Nesterova
YGYelena Yu. Glinka
Yelena Yu. Glinka
VPValentina N. Perfilova
Valentina N. Perfilova
ANAlla A. Nesterova
Alla A. Nesterova
KKKamil D. Kaplanov
Kamil D. Kaplanov
ГЮГлинка Елена Юрьевна
Глинка Елена Юрьевна
-Isomer of Klotho Protein has been actively studied over the past 20 years. It has been found that -Klotho is closely associated with aging and has anti-aging properties. Besides, it is involved in development of malignant tumor diseases. Its universal influence on many biological mechanisms leading to hyperplastic changes in cells and tissues has been proven experimentally. Recent studies demonstrated inhibitory effect of -Klotho on the classical carcinogenic pathways such as insulin-like growth factor 1 (IGF1), fibroblast growth factor (FGFs), transforming growth factor 1 (TGFb1), Wnt, P53/p21, oxidative stress response pathways. Impeding effect of -Klotho protein on the development of such types of malignant tumors as breast, pancreatic, lung, stomach, hepatocarcinoma, and others is proven in a number of cases. This review describes the role of -Klotho in oncogenesis, its involvement and influence on the main signaling pathways known for their role in the development of malignant tumors, and the possibility of regulating its expression.